A 43-year-old female was admitted to our intensive care liver unit because of hypovolemic shock secondary to a spontaneous liver rupture. When she was twenty years old, she developed an adrenal carcinoma requiring left adrenalectomy, nephrectomy and splenectomy. Since then, she has been treated with mitotane, alongside hydrocortisone and fludrocortisone for mitotane-related adrenal insufficiency. She also developed primary hypogonadism due to mitotane treatment and was on hormonal treatment with estradiol and norethisterone.